Background: P16 immunohistochemistry (IHC) is a reliable surrogate marker for human papillomavirus (HPV) causation in oropharyngeal squamous cell carcinoma (OPSCC) and is requested on neck FNA. However, p16 IHC is not validated on cytology cell blocks with no established interpretation guidelines. Objective: The current study compared p16 IHC in cytology and surgical specimens, to devise criteria for accurate p16 evaluation in cytology cell blocks to ensure close to 100% specificity of a positive result. Method: p16 IHC was examined in 27 matched FNA and surgical cases of OPSCC over a two-year period. Fifty viable basaloid tumor cells in clusters were considered adequate. Both cytoplasmic and nuclear staining was evaluated. Extent of nuclear p16 staining was scored as <25%, 25%-50%, 50%-75% or >75%; intensity was scored as mild, moderate, or intense. Results: Three of 27 were p16 negative on both the cytology and surgical specimens, and served as negative controls. The remaining 24 cases were p16 positive on the surgical specimens. Eight were excluded due to low cellularity or presence of only desquamated individual keratinized tumor cells. Six of 27 showed >75% cells with weak-intense nuclear staining. Three of 27 showed 50%-75% cells with weak-intense nuclear staining. One of 27 had weak nuclear staining in <25% cells. Three of 27 showed only weak cytoplasmic staining. Three of 27 had no nuclear or cytoplasmic staining. Conclusion: At least 50 viable basaloid cells in small groups should be assessed. Cells with any cytoplasmic staining should be evaluated for nuclear staining. A threshold of 25% nuclear staining results in a specificity of 100%. 
Background:
The new nomenclature of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) reflects the indolent clinical and biologic behavior of noninvasive follicular variant of papillary thyroid carcinomas, which can be managed conservatively. Given the critical role of fine-needle aspiration (FNA) cytology in the pre-operative assessment and triaging of thyroid nodules, the aim of this study was to investigate the corresponding cytologic diagnoses of NIFTP nodules and gene expression classifier (GEC) results. Methods: We performed a retrospective review of thyroid nodules histologically diagnosed as NIFTP at our institution between April 1 and December 31, 2016. The following data points were collected: demographics, nodule size, pre-operative cytologic diagnosis, GEC results, and origin of sample (in-house vs outside hospital). Results: The case cohort included 53 nodules diagnosed as NIFTP (size range 1-7 cm, mean size 2.7 cm) from 51 patients (age range 23-82, mean age 51.4, M:F 1:4.7). Corresponding FNA cytologic results were available for 48 nodules (90.6%); of these, 23 were from outside cases re-reviewed before the patient's surgery at our institution. The cytologic diagnoses were benign (n = 4, 8.3%), atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS; n = 16, 33.3%), follicular neoplasm (FN; n = 14, 29.2%), follicular neoplasm with oncocytic features (FNOF; n = 6, 12.5%), suspicious for papillary thyroid carcinoma (sPTC; n = 5, 10.4%) and PTC (n = 3, 6.3%). GEC results were available for 21 (43.8%) nodules, including six from outside cases that were originally diagnosed as AUS/FLUS and reclassified as benign, FN, FNOF, and PTC upon re-review. By GEC analysis, the majority of cases were classified as suspicious (n = 16, 76.2%), followed by benign (n = 4, 19%), and indeterminate (n = 1, 4.8%).
Conclusion:
The majority of thyroid nodules histologically diagnosed as NIFTP have indeterminate cytology (75%) and are classified as suspicious (76.2%) by GEC testing. 
